Funding for this research was provided by:
National Institute on Aging (U01 AG057195, P30 AG010133, R56 AG057195, NIH/NIA U01 AG024904, K02 AG048240, R01 AG040770, K01 AG049050)
Received: 24 October 2019
Accepted: 23 June 2020
First Online: 5 August 2020
Ethics approval and consent to participate
: All procedures were approved by the Institutional Review Boards of all participating institutions. Written informed consent was obtained from every research participant according to the Declaration of Helsinki and the Belmont Report. The analyses reported here were conducted under Indiana University IRB protocol #1506941363 (exempt).
: Not applicable.
: Eddie Stage, PhD, reports no competing interests.Meredith Phillips, MS, reports no competing interests.Victor Hugo Canela, MS, reports no competing interests.Tugce Duran, BS, reports no competing interests.Naira Goukasian, BS, reports no competing interests.Shannon L. Risacher, PhD, reports no competing interests.Andrew J. Saykin, PsyD, has received research support from Eli Lilly and AVID Radiopharmaceuticals.Liana G. Apostolova, MD, MS, has served on an Advisory Board for Eli Lilly and Biogen and on the Speakers Bureau for Piramal and Eli Lilly.